Pashtoon Kasi, Director for Colorectal Cancer Research at Weill Cornell Medicine, shared on X:
“🆕🗞️Just out
NEST-1 trial results
Are we on the verge of a new drug combo for colon or rectal cancer?
Substantial & brisk responses to just☝🏾dose of BOT (botensilimab)🟢➕BAL (balstilimab)🔹🔹 immunotherapy.🙌🏾
Pattern & kill is unprecedented🌊.
Abstract 117📍Poster Board H2″
Source: Pashtoon Kasi / X